［1］ Parkin D M,Bray F,Ferlay J,et al.Global cancer statistics［J］.C A Cancer J Clin,2005,55﹙2﹚:74.
[2] Mizoshita T,Kataoka H,Kubota E,et al.Gastricphenotype signetring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential meth-otrexate and 5-fluorouracil［J］.Int J Clin Oncol,2008,13﹙4﹚:373.
[3] Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer ［J］.Ann Oncol,1997,8（2）:163-168.
[4] Alberts S R，Cervantes A，VANDE Velde C J，et al .Gastric cancer: epidemiology，pathology and treatment ［J］.Ann Oncol,2003，14(suppl 2):S31.
[5] Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a review of clinical trials in Japan 2002［J］.Gan To Kaggku Ryobo,2002,29﹙9﹚:1522.
[6] 白坂哲彦，佃守犬山，扶他新规.经口抗癌剂TS-1（S-1）［J］.癌症化学疗法,2001,28(6):855.
[7] Koizumi W， Akiya T， Sato A， et al. Phase Ⅱ study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study ［J］. Cancer Chemother Pharmacol，2010，65(6)：1093-1099.
[8] Koizumi W.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer.(SPIRITS trial):a phase III trial ［J］.Lancet Oncol,2008,9(3):215.
[9] Boku N.Chemotherapy for metastatic disease:review from JCOG trial［J］.International Journal of Clinical Oncology,2008,13(3):196.
[10] Al Batran S E，Atmaca A，Hegewisch-Becker S，et al. Phase II trial of biweekly infusional fluorouracil， folinic acid， and oxaliplatin in patients with advanced gastric cancer ［J］. J Clin Oncol，2004；22：658-663.
[11] 张晓南，卞晓山，魏长宏，等.国产奥沙利铂联合亚叶酸钙和氟尿嘧啶治疗晚期胃癌42例［J］.武警医学，2006,17(6):447.